Spring Bank Pharmaceuticals - 48 Year Dividend Yield History | SBPH

Historical dividend payout and yield for Spring Bank Pharmaceuticals (SBPH) since 1971. The current TTM dividend payout for Spring Bank Pharmaceuticals (SBPH) as of March 25, 2019 is $0.00. The current dividend yield for Spring Bank Pharmaceuticals as of March 25, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.158B $0.000B
Spring Bank Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of therapeutics using its proprietary small molecule nucleic acid hybrid chemistry platform. The company is developing SB 9200, for the treatment of viral diseases, including hepatitis B virus. Spring Bank Pharmaceuticals, Inc. is based in Hopkinton, United States.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $116.179B 12.96
Gilead Sciences (GILD) United States $81.339B 10.35
Bio-Techne Corp (TECH) United States $7.264B 48.94